Persistent HIV‐1 replication does not explain low levels of T‐cell interferon‐γ mRNA and elevated serum NO2–/NO3– in patients with stable CD4 T‐cell responses to HAART

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical and Experimental Immunology

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2249.2004.02589.xPMID 15373912PMCID PMC1809174
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Restoration of CD4 T‐cell responses to cytomegalovirus is short‐lived in severely immunodeficient HIV‐infected patients responding to highly active antiretroviral therapy

  2004cited by this paper
• Close link between CD4+ and CD8+ T cell proliferation defects in patients with human immunodeficiency virus disease and relationship to extended periods of CD4+ lymphopenia.

  2002cited by this paper
• Immunological markers predicting outcome in patients with hepatitis C treated with interferon‐α and ribavirin

  2002cited by this paper
• CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy.

  2002cited by this paper
• A Balanced Type 1/Type 2 Response Is Associated with Long-Term Nonprogressive Human Immunodeficiency Virus Type 1 Infection

  2002cited by this paper
• Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production

  2002cited by this paper
• Immunological and virological features of HIV‐infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor‐based therapy

  2002cited by this paper
• An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

  2001cited by this paper
• Nitric oxide and bone

  2001cited by this paper
• Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patients.

  2001cited by this paper
• Impaired replication of protease inhibitor-resistant HIV-1 in human thymus

  2001cited by this paper
• CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease

  2000cited by this paper
• Assessment of Immune Function by Lymphoproliferation Underestimates Lymphocyte Functional Capacity in HIV Patients Treated with Highly Active Antiretroviral Therapy

  2000cited by this paper
• Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen.

  1999cited by this paper
• Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease.

  1999cited by this paper
• Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy.

  1999cited by this paper
• Assessment of Type 1 and Type 2 Cytokines in HIV Type 1-Infected Individuals: Impact of Highly Active Antiretroviral Therapy

  1999cited by this paper
• Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo.

  1999cited by this paper
• CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)

  1998cited by this paper
• CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study.

  1998cited by this paper
• CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection

  1998cited by this paper
• Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

  1998cited by this paper
• Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.

  1998cited by this paper
• Unbalanced production of interleukin-5 and interleukin-2 in children with atopic dermatitis.

  1997cited by this paper
• Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.

  1997cited by this paper
• Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

  1997cited by this paper
• CD30 expression on human CD8+ T cells isolated from peripheral blood lymphocytes of normal donors.

  1996cited by this paper
• Preferential expression of CD30 by human CD4+ T cells producing Th2‐type cytokines

  1995cited by this paper
• The Th1-Th2 hypothesis of HIV infection: new insights.

  1994cited by this paper
• CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection

  1994cited by this paper

• VIH/Sida, Breve história de uma nova/velha infeção

  2016cites this paper
• Temporal Characterization of Marburg Virus Angola Infection following Aerosol Challenge in Rhesus Macaques

  2015cites this paper
• Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1–TH2 cytokine profile in subjects with self‐limited disease

  2007cites this paper
• A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy

  2006cites this paper